Kailera Therapeutics: Initial Ownership Filing
Ticker: KLRA · Form: 3 · Filed: Apr 16, 2026
Sentiment: neutral
Topics: insider-filing, ownership, pharmaceuticals
TL;DR
Kailera Therapeutics insider Frank Clyburn filed initial ownership docs. Watch this space.
AI Summary
On April 16, 2026, Frank Clyburn (CIK 0001763963) filed an initial statement of beneficial ownership of securities (Form 3) for Kailera Therapeutics, Inc. (CIK 0002096997). The filing details ownership of securities related to the pharmaceutical preparations company.
Why It Matters
This Form 3 filing indicates the initial beneficial ownership of securities by an insider, which can provide early insights into potential insider confidence or strategic moves within Kailera Therapeutics.
Risk Assessment
Risk Level: low — A Form 3 filing is a standard initial disclosure and does not inherently indicate increased risk.
Key Players & Entities
- Kailera Therapeutics, Inc. (company) — Issuer
- Frank Clyburn (person) — Reporting Person
- 0001763963 (person) — CIK for Frank Clyburn
- 0002096997 (company) — CIK for Kailera Therapeutics, Inc.
- 2026-04-16 (date) — Period of Report and Filing Date
FAQ
What type of filing is this?
This is a Form 3, an initial statement of beneficial ownership of securities.
Who is the reporting person?
The reporting person is Frank Clyburn, with CIK 0001763963.
What company is this filing related to?
The filing is related to Kailera Therapeutics, Inc., with CIK 0002096997.
When was the filing made?
The filing was made on April 16, 2026.
What is the business of Kailera Therapeutics, Inc.?
Kailera Therapeutics, Inc. is in the Pharmaceutical Preparations industry (SIC 2834).
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 16, 2026 by Frank Clyburn regarding Kailera Therapeutics, Inc. (KLRA). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.